These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 26200514)

  • 1. MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY.
    Garg SJ; Dollin M; Storey P; Pitcher JD; Fang-Yen NH; Vander J; Hsu J;
    Retina; 2016 Feb; 36(2):351-9. PubMed ID: 26200514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection.
    Patel SN; Storey PP; Pancholy M; Obeid A; Wibbelsman TD; Levin H; Hsu J; Garg SJ; Dunn JP; Vander JF
    Am J Ophthalmol; 2019 Nov; 207():224-231. PubMed ID: 31201794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes.
    Simunovic MP; Rush RB; Hunyor AP; Chang AA
    Br J Ophthalmol; 2012 Jun; 96(6):862-6. PubMed ID: 22446145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistently Vitreous Culture-Positive Exogenous Bacterial Endophthalmitis.
    Leung EH; Kuriyan AE; Flynn HW; Miller D; Huang LC
    Am J Ophthalmol; 2016 May; 165():16-22. PubMed ID: 26921804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Study of Microbiological Profile and Management Outcomes of Acute Endophthalmitis after Microincision Vitrectomy Surgery versus Intravitreal Injections.
    Kannan NB; Sen S; Mishra C; Lalitha P; Rameshkumar G; Rajan RP; Arumugam KK; Ramasamy K
    Ocul Immunol Inflamm; 2021 Jul; 29(5):838-844. PubMed ID: 31900009
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes.
    Lalwani GA; Flynn HW; Scott IU; Quinn CM; Berrocal AM; Davis JL; Murray TG; Smiddy WE; Miller D
    Ophthalmology; 2008 Mar; 115(3):473-6. PubMed ID: 18067969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endophthalmitis after pars plana vitrectomy: results of the Pan American Collaborative Retina Study Group.
    Wu L; Berrocal MH; Arévalo JF; Carpentier C; Rodriguez FJ; Alezzandrini A; Farah ME; Roca JA; Maia M; Saravia M; Morales-Cantón V; Graue-Wiechers F; Cardillo JA
    Retina; 2011 Apr; 31(4):673-8. PubMed ID: 21394065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands.
    Pijl BJ; Theelen T; Tilanus MA; Rentenaar R; Crama N
    Am J Ophthalmol; 2010 Mar; 149(3):482-7.e1-2. PubMed ID: 20053391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric posttraumatic endophthalmitis.
    Wu H; Ding X; Zhang M; Xu G
    Graefes Arch Clin Exp Ophthalmol; 2016 Oct; 254(10):1919-1922. PubMed ID: 27067874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Nine-Year Analysis of Practice Patterns, Microbiologic Yield, and Clinical Outcomes in Cases of Presumed Infectious Endophthalmitis.
    Feng HL; Robbins CB; Fekrat S
    Ophthalmol Retina; 2020 Jun; 4(6):555-559. PubMed ID: 32387054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes.
    Scott IU; Flynn HW; Dev S; Shaikh S; Mittra RA; Arevalo JF; Kychenthal A; Acar N
    Retina; 2008 Jan; 28(1):138-42. PubMed ID: 18185150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor.
    Mezad-Koursh D; Goldstein M; Heilwail G; Zayit-Soudry S; Loewenstein A; Barak A
    Retina; 2010; 30(7):1051-7. PubMed ID: 20616683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors: Management and Visual Outcomes.
    Xu K; Chin EK; Bennett SR; Williams DF; Ryan EH; Dev S; Mittra RA; Quiram PA; Davies JB; Parke DW; Johnson JB; Cantrill HL; Almeida DRP
    Ophthalmology; 2018 Aug; 125(8):1279-1286. PubMed ID: 29477689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.
    Moshfeghi AA; Rosenfeld PJ; Flynn HW; Schwartz SG; Davis JL; Murray TG; Smiddy WE; Berrocal AM; Dubovy SR; Lee WH; Albini TA; Lalwani GA; Kovach JL; Puliafito CA
    Retina; 2011 Apr; 31(4):662-8. PubMed ID: 21836400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes.
    Busbee BG; Recchia FM; Kaiser R; Nagra P; Rosenblatt B; Pearlman RB
    Ophthalmology; 2004 Aug; 111(8):1495-503; discussion 1503. PubMed ID: 15288977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia.
    Al-Rashaed S; Alsulaiman SM; Alrushood AA; Almasaud J; Arevalo JF
    Middle East Afr J Ophthalmol; 2016; 23(1):60-3. PubMed ID: 26957840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive use of intravitreal dexamethasone in presumed bacterial endophthalmitis: a randomised trial.
    Albrecht E; Richards JC; Pollock T; Cook C; Myers L
    Br J Ophthalmol; 2011 Oct; 95(10):1385-8. PubMed ID: 21289020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.
    Dossarps D; Bron AM; Koehrer P; Aho-Glélé LS; Creuzot-Garcher C;
    Am J Ophthalmol; 2015 Jul; 160(1):17-25.e1. PubMed ID: 25892127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
    Storey P; Dollin M; Pitcher J; Reddy S; Vojtko J; Vander J; Hsu J; Garg SJ;
    Ophthalmology; 2014 Jan; 121(1):283-289. PubMed ID: 24144453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.